Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone

Molecular Cancer Therapeutics

Volumn 1, Issue 11, 2002, Pages 893-899

  Burdelya, Lyudmila ^a   Catlett Falcone, Robyn ^a   Levitzki, Alexander ^b   Cheng, Fengdong ^a   Mora, Linda B ^a   Sotomayor, Eduardo ^a   Coppola, Domenico ^a   Sun, JiaZhi ^a   Sebti, Said ^a   Dalton, William S ^a   Jove, Richard ^a   Yu, Hua ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TYRPHOSTIN; TYRPHOSTIN AG-490;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; NICK END LABELING; PERITONEUM MACROPHAGE; SIGNAL TRANSDUCTION; SPLEEN; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL NUCLEUS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASMS; SIGNAL TRANSDUCTION; SPLEEN; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0036727740     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J. F., Capiod, J. C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87: 1692-1697, 1996. (Pubitemid 26068885)
2. Weber-Nordt, R. M., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R., and Finke, J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88: 809-816, 1996. (Pubitemid 26333300)
3. Chai, S. K., Nichols, G. L., and Rothman, P. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol., 159: 4720-4728, 1997. (Pubitemid 127471006)
4. Garcia, R., Yu, C. L., Hudnall, A., Catlett, R., Nelson, K. L., Smithgall, T., Fujita, D. J., Ethier, S. P., and Jove, R. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ., 8: 1267-1276, 1997. (Pubitemid 28008723)
5. Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., and Tweardy, D. J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Investig., 102: 1385-1392, 1998. (Pubitemid 28467567)
6. Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nunez, G., Dalton, W. S., and Jove, R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10: 105-115, 1999. (Pubitemid 29077388)
7. Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T. S., Patel, B. K., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., Leonard, W. J., Waldmann, T., and Franchini, G. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA, 94: 13897-13902, 1997. (Pubitemid 28009681)
8. Liu, R. Y., Fan, C., Garcia, R., Jove, R., and Zuckerman, K. S. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines. Blood, 93: 2369-2379, 1999. (Pubitemid 29153641)
9. Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., and Sawyers, C. L. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene, 13: 247-254, 1996. (Pubitemid 26334856)
10. Carlesso, N., Frank, D. A., and Griffin, J. D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med., 183: 811-820, 1996. (Pubitemid 26113953)
11. Frank, D. A., and Varticovski, L. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia (Baltimore), 10: 1724-1730, 1996. (Pubitemid 26380018)
12. Ilaria, R. L., Jr., and Van Etten, R. A. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem., 271: 31704-31710, 1996. (Pubitemid 26408636)
13. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., and Darnell, J. E., Jr. Stat3 as an oncogene. Cell, 98: 295-303, 1999. (Pubitemid 29380565)
14. Hallek, M., Bergsagel, P. L., and Anderson, K. C. Multiple myeloma: Increasing evidence for a multistep transformation process. Blood, 91: 3-21, 1998. (Pubitemid 28018724)
15. Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., Laudano, A., Gazit, A., Levitzki, A., Kraker, A., and Jove, R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene, 20: 2499-2513, 2001. (Pubitemid 32531347)
16. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C. M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (Lond.), 379: 645-648, 1996. (Pubitemid 26053453)
17. Wang, L. H., Kirken, R. A., Erwin, R. A., Yu, C. R., and Farrar, W. L. JAK3. STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J. Immunol., 162: 3897-3904, 1999. (Pubitemid 29314768)
18. Puisieux, I., Odin, L., Poujol, D., Moingeon, P., Tartaglia, J., Cox, W., and Favrot, M. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and longterm antitumoral immunity. Hum. Gene Ther., 9: 2481-2492, 1998. (Pubitemid 29004621)
19. Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., Liao, F., Farber, J. M., Pestka, S., Trinchieri, G., and Lee, W. M. Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity, 9: 25-34, 1998. (Pubitemid 28361292)
20. Bacon, C. M., Petricoin, I. E. F., Ortaldo, J. R., Rees, R. C., Larner, A. C., Johnston, J. A., and O'Shea, J. J. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA, 92: 7307-7311, 1995.
21. Bright, J. J., and Sriram, S. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol., 161: 1772-1777, 1998. (Pubitemid 28387596)
22. Ahn, H. J., Tomura, M., Yu, W. G., Iwasaki, M., Park, W. R., Hamaoka, T., and Fujiwara, H. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-γ production following IL-12 stimulation. J. Immunol., 161: 5893-5900, 1998. (Pubitemid 28535956)
23. Yu, C. R., Lin, J. X., Fink, D. W., Akira, S., Bloom, E. T., and Yamauchi, A. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-α. J. Immunol., 157: 126-137, 1996. (Pubitemid 26190539)
24. Gately, M. K., Warrier, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R., and Murphy, M. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol., 6: 157-167, 1994. (Pubitemid 24040344)
25. Tsung, K., Meko, J. B., Peplinski, G. R., Tsung, Y. L., and Norton, J. A. IL-12 induces T helper 1-directed antitumor response. J. Immunol., 158: 3359-3365, 1997. (Pubitemid 127484054)
26. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., and Jove, R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (Wash. DC), 269: 81-83, 1995.
27. Schroder, C. P., and Maurer, H. R. Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro. Cancer Immunol. Immunother., 50: 69-76, 2001. (Pubitemid 32424490)
28. Matera, L., and Mori, M. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-γ by natural killer and T cells. Ann. N. Y. Acad. Sci., 919: 505-513, 2000.
29. Tan, J., Newton, C. A., Djeu, J. Y., Gutsch, D. E., Chang, A. E., Yang, N. S., Klein, T. W., and Yu, H. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res, 56: 3399-3403, 1996. (Pubitemid 26251626)
30. Wong, H. L., Wilson, D. E., Jenson, J. C., Familletii, P. C., Stremlo, D. L., and Gately, M. K. Characterization of factor which synergizes with recombinant interleukin-12 in promoting allogenic human cytolytic T-lymphocyte responses in vitro. Cell. Immunol., 111: 39-54, 1988. (Pubitemid 18057047)
31. Bright, J. J., Du, C., and Sriram, S. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J. Immunol., 162: 6255-6262, 1999. (Pubitemid 29314990)
32. Constantin, G., Brocke, S., Izikson, A., Laudanna, C., and Butcher, E. C. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. Eur. J. Immunol., 28: 3523-3529, 1998. (Pubitemid 28510763)
33. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., and Godfrey, D. I. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol., 14: 165-171, 2002. (Pubitemid 34188474)